Björn Stollenwerk - Concepedia

Author

Björn Stollenwerk

Helmholtz Zentrum München ORCID

Also Known As

B Stollenwerk, B. Stollenwerk, Bjoern Stollenwerk, Bjorn Stollenwerk, Björn Stollenwerk, Stollenwerk, Björn

102

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Helmholtz Zentrum München University of Cologne Amgen (Switzerland)Ludwig-Maximilians-Universität München University Hospital Cologne

About

Björn Stollenwerk is an author at Helmholtz Zentrum München specializing in medicine, health economics, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	886
2	Management	4	4	106
3	Business	2	2	43
4	Health Sciences	1	1	19
5	Nursing	1	1	19

Björn Stollenwerk

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières, The Lancet Non-small-cell Lung CancerMedicinePathologyCancer TreatmentCancer Genetics	2023	507
Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany Markus Lüngen, Björn Stollenwerk, Philipp Messner, International Journal for Equity in Health	2008	179
Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation Matthias Hünger, Carla Sabariego, Björn Stollenwerk, Quality of Life Research Cognitive RehabilitationStroke RehabilitationMedicineFunctional RecoveryPatients Undergoing Rehabilitation	2011	117
Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study Christa Meisinger, Björn Stollenwerk, Inge Kirchberger, BMC Geriatrics	2013	52
Economic evaluation of genetic screening for Lynch syndrome in Germany Franziska Severin, Björn Stollenwerk, Elke Holinski‐Feder, Genetics in Medicine Genetic TestingGenetic DisorderGenetic EpidemiologyPediatricsPublic Health	2015	44
Sex Differences in Treatment Patterns of Six Chronic Diseases: An Analysis from the German Statutory Health Insurance Stephanie Stock, Björn Stollenwerk, Marcus Redaèlli, Journal of Women s Health	2008	42
Financial incentives in the German Statutory Health Insurance: New findings, new questions Stephanie Stock, Harald Schmidt, Guido Büscher, Health Policy Financial ProtectionHealth Care FinanceNew FindingsManagementHealth Financing	2010	40
Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation Dirk Müller, Marion Danner, Kerstin Rhiem, The European Journal of Health Economics German WomenDifferent StrategiesBreast OncologyBrca 1Medicine	2017	40
The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance Bettina Butzke, Fuat Oduncu, Franziska Severin, Acta Oncologica	2015	37
C-Reactive Protein Levels and Post-ICU Mortality in Nonsurgical Intensive Care Patients Wilhelm Grander, Martin W. Dünser, Björn Stollenwerk, CHEST Journal InflammationCritical Care MedicineAcute CarePatient SafetyInflammatory Marker	2010	36

Page 1